<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04420429</url>
  </required_header>
  <id_info>
    <org_study_id>BeyogluEREH</org_study_id>
    <nct_id>NCT04420429</nct_id>
  </id_info>
  <brief_title>The Effect Of Preoperative Parameters On Success After DMEK Surgery</brief_title>
  <official_title>The Effect Of Preoperative Anterior Segment Parameters On Success After Descemet Membrane Endothelial Keratoplasty (Dmek) Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beyoglu Eye Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beyoglu Eye Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effect of preoperative parameters on surgical
      results in Descemet Membrane Endothelial Keratoplasty (DMEK) surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients undergoing Descemet Membrane Endothelial Keratoplasty (DMEK) surgery;
      preoperative anterior chamber depth, angle parameters, axial length and corneal parameters
      will be evaluated. The effects of these parameters on surgical results will be examined.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Change in visual acuity</measure>
    <time_frame>Baseline and after surgery 1, 3, 6, and 12 months</time_frame>
    <description>Change from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in endothelial cell density</measure>
    <time_frame>after surgery 1, 3, 6, and 12 months</time_frame>
    <description>Change from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in maximum (steepest) and minimum (flattest) keratometry values in the central corneal zone</measure>
    <time_frame>Baseline and after surgery 1, 3, 6, and 12 months</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in anterior chamber depth</measure>
    <time_frame>Baseline and after surgery 1, 3, 6, and 12 months</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in axial length</measure>
    <time_frame>Baseline and after surgery 1, 3, 6, and 12 months</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in central pachymetry</measure>
    <time_frame>Baseline and after surgery 1, 3, 6, and 12 months</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in intraocular pressure</measure>
    <time_frame>Baseline and after surgery 1, 3, 6, and 12 months</time_frame>
    <description>Change from baseline</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Surgical complications</measure>
    <time_frame>During surgery</time_frame>
    <description>Complications occurring during the surgery will be recorded.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Fuchs' Endothelial Dystrophy</condition>
  <condition>Pseudophakic Bullous Keratopathy</condition>
  <condition>Descemet's Membrane; Defect</condition>
  <condition>Herpetic Keratitis</condition>
  <condition>Angle's Classification</condition>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>Cohort</arm_group_label>
    <description>All patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Descemet membrane endothelial keratoplasty (DMEK)</intervention_name>
    <description>All participants underwent DMEK surgery</description>
    <arm_group_label>Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who developed pseudophakic bullous keratopathy, Fuchs endothelial dystrophy,
        endothelial insufficiency after herpetic endotheliitis and associated permanent corneal
        edema and therefore DMEK surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled to undergo Descemet membrane endothelial keratoplasty(DMEK)

          -  aged 18 old older

        Exclusion Criteria:

          -  Patients with corneal pathology other than endothelial insufficiency

          -  Glaucoma patients,

          -  Patients who have previously had any keratoplasty procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Semih Çakmak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beyoglu Eye Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Semih Çakmak, MD</last_name>
    <phone>+90 2122515900</phone>
    <phone_ext>351</phone_ext>
    <email>semihnr@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beyoğlu Eye Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34420</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Semih Çakmak, MD</last_name>
      <phone>+90 212 2515900</phone>
      <phone_ext>351</phone_ext>
      <email>semihnr@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Semih Çakmak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ahmet Kırgız, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 16, 2020</study_first_submitted>
  <study_first_submitted_qc>June 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 6, 2020</last_update_submitted>
  <last_update_submitted_qc>June 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beyoglu Eye Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Semih Çakmak</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Descemet Membrane</keyword>
  <keyword>anterior chamber depth</keyword>
  <keyword>axial length</keyword>
  <keyword>endothelial count</keyword>
  <keyword>Descemet membrane endothelial keratoplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratitis, Herpetic</mesh_term>
    <mesh_term>Malocclusion</mesh_term>
    <mesh_term>Keratitis</mesh_term>
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 24, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/29/NCT04420429/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 24, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/29/NCT04420429/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

